DSGN icon

Design Therapeutics

83 hedge funds and large institutions have $413M invested in Design Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.82M
Puts
$1.24M
Net Calls
Net Calls Change

Top Buyers

1 +$21.8M
2 +$9.23M
3 +$3.85M
4
Bank of America
Bank of America
North Carolina
+$2.35M
5
Rafferty Asset Management
Rafferty Asset Management
New York
+$2.18M

Top Sellers

1 -$19.5M
2 -$16.8M
3 -$7.64M
4
Goldman Sachs
Goldman Sachs
New York
-$7.38M
5
TCM
Tekla Capital Management
Massachusetts
-$4.69M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$148K
52
$140K
53
$140K
54
$139K
55
$135K
56
$130K
57
$128K
58
$126K
59
$119K
60
$110K
61
$44K
62
$40K
63
$33K
64
$32.1K
65
$23.1K
66
$22K
67
$17.1K
68
$11.4K
69
$11.4K
70
$10.3K
71
$10.2K
72
$7.63K
73
$5.83K
74
$5.13K
75
$2.06K